Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.
Rascol O, Arnulf I, Peyro-Saint Paul H, Brefel-Courbon C, Vidailhet M, Thalamas C, Bonnet AM, Descombes S, Bejjani B, Fabre N, Montastruc JL, Agid Y.
Rascol O, et al. Among authors: fabre n.
Mov Disord. 2001 Jul;16(4):708-13. doi: 10.1002/mds.1143.
Mov Disord. 2001.
PMID: 11481696
Clinical Trial.